For instance, the downregulation of GSDMD can significantly boost the proliferation and metastasis of gastric cancer cells [21], while the overexpression of GSDMB is related to reduced survival, easy invasion, and increased metastasis in breast cancer cells, predicting low sensitivity to targeted therapy [22]. This evidence concerns the gene GSDMD and breast carcinoma.